Compound information
- Natural Products
- ZC1697401
- Molecular Formula
- C17H19N3O
- Molecular Weight
- 281.152812228 g/mol
- Structure
-
- IUPAC Name
- (3R)-3-benzyl-N-(3-pyridyl)pyrrolidine-1-carboxamide
- InChI
- InChI=1S/C17H19N3O/c21-17(19-16-7-4-9-18-12-16)20-10-8-15(13-20)11-14-5-2-1-3-6-14/h1-7,9,12,15H,8,10-11,13H2,(H,19,21)/t15-/m0/s1
- InChI Key
- IEQFYVGDZHFIAQ-HNNXBMFYSA-N
- SMILES
- O=C(Nc1cccnc1)N1CC[C@@H](Cc2ccccc2)C1
- Source
- ZINC000095403840
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 21 | Ring Count | 3 |
Heteroatom Count | 4 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 2 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 45.23 Å2 | LogP | 3.27 |
LogS | -2.884 | LogD | 2.36 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.089 | Pgp substrate | 0.048 |
HIA | 0.968 | F20 % | 0.99 |
F30 % | 0.886 | Caco-2 | -4.71 |
MDCK | -4.965 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.821 | PPB | 57.728 |
VD | 1.304 | Fu | 0.742 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.95 | CYP1A2 substrate | 0.75 |
CYP2A6 substrate | 0.803 | CYP2B6 substrate | 0.773 |
CYP2C19 inhibitor | 0.684 | CYP2C19 substrate | 0.773 |
CYP2C8 substrate | 0.72 | CYP2C9 inhibitor | 0.734 |
CYP2C9 substrate | 0.964 | CYP2D6 inhibitor | 0.607 |
CYP2D6 substrate | 0.989 | CYP2E1 substrate | 0.887 |
CYP3A4 inhibitor | 0.762 | CYP3A4 substrate | 0.993 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.783 | CL | 9.835 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.535 | Hepatotoxicity | 0.904 |
Mutagenicity | 0.001 | Rat Oral Acute Toxicity | 0.047 |
FDAMDD | 0.434 | Skin Sensitization | 0.999 |
Carcinogenicity | 0.106 | Eye Corrosion | 0.002 |
Eye Irritation | 0.571 | Respiratory Toxicity | 0.689 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.236 | IGC50 | 3.332 |
LC50FM | 3.156 | LC50DM | 1.506 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.192 | NR-AR-LBD | 0.179 |
NR-AhR | 0.593 | NR-Aromatase | 0.06 |
NR-ER | 0.369 | NR-ER-LBD | 0.285 |
NR-PPAR-gamma | 0.234 | SR-ARE | 0.582 |
SR-ATAD5 | 0.517 | SR-HSE | 0.299 |
SR-MMP | 0.815 | SR-p53 | 0.05 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.